News for Midatech Pharma plc (MTP)

Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”)Biodexa CEO Issues Shareholder Letter Highlighting Progress in 2023 and Expected Milestones...

GENEVA — The Wyss Center, a leading non-profit research center dedicated to innovating and accelerating technologies and therapies for neurological and mental…

NEW HAVEN, Conn., June 20, 2023 -- BIOASIS TECHNOLOGIES INC. , a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factor... | June 20, 2023

NEW HAVEN, Conn., June 20, 2023 (GLOBE NEWSWIRE) —

Biodexa Pharmaceuticals PLC?Annual Report 2022Biodexa Pharmaceuticals PLCAnnual Report 2022 ... | June 1, 2023

28 April 2023 Biodexa Pharmaceuticals PLC Preliminary Results for the Year Ended 31 December 2022 Biodexa Pharmaceuticals PLC ,... | April 28, 2023

[210 + Pages Report] According to Zion Market Research, the global artificial saliva market size was valued at around USD 8.7 billion in 2022 and is...

Midatech Pharma Announces R&D Programme Focused on Leptomeningeal Disease

Midatech Pharma PLC - Cardiff-based R&D biotechnology company focused on improving the bio-delivery and bio-distribution of medicines - Says resolutions put forward at general meeting, including... | March 24, 2023

THIS ANNOUNCEMENT DOES NOT CONSTITUTE OR CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION, OFFER OR ADVICE TO ANY PERSON TO SUBSCRIBE FOR OR OTHERWISE ACQUIRE ANY SECURITIES OF THE... | February 9, 2023

NEW HAVEN, Conn., Feb. 03, 2023 (GLOBE NEWSWIRE) —

NEW HAVEN, Conn., Feb. 03, 2023 -- BIOASIS TECHNOLOGIES INC. , a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factor... | February 3, 2023

NEW HAVEN, Conn., Jan. 23, 2023 -- BIOASIS TECHNOLOGIES INC. , a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factor... | January 23, 2023

Octopus AIM VCT 2 plc Half-Yearly Results Octopus AIM VCT 2 plc (the “Company”) is a venture capital trust (“VCT”) which aims to...

Wilmington, Delaware, United States: The pancreas is anatomically so placed that any growth here affects multiple organs like the stomach, gall bladder and intestines.

Gainers

Gainers

Octopus AIM VCT 2 plc 18 August 2021 Portfolio Update The investment portfolio of Octopus AIM VCT 2 plc (the "Company") as at 18 August 2021 is as...